Related Experiment Video
Updated: Jun 20, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Prevention and treatment of contrast-associated nephropathy in interventional cardiology
Adriano Caixeta1, Eugenia Nikolsky, Roxana Mehran
1Data Coordinating & Analysis Center, Cardiovascular Research Foundation, New York, NY 10022, USA.
Insights
Contrast-induced nephropathy (CIN) is a frequent complication following cardiovascular procedures, particularly in high-risk patients. Current prevention strategies focus on patient selection, contrast volume reduction, and hydration, with drug efficacy still under investigation.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication post-cardiovascular procedures.
- CIN is associated with increased mortality and morbidity.
- High-risk patient groups include the elderly and those with chronic kidney disease, heart failure, and diabetes.
Purpose of the Study:
- To review current understanding and management of CIN.
- To highlight the limitations of existing preventive strategies.
- To discuss the potential role of pharmacological agents and contrast media types.
Main Methods:
- Literature review of studies on CIN prevention.
- Analysis of risk factors and current clinical practices.
- Evaluation of the efficacy of different contrast agents and potential drugs.
Main Results:
- No definitive preventive strategies beyond hydration and contrast reduction are established.
- The effectiveness of various drugs in preventing CIN remains controversial.
- Nonionic, low-osmolar contrast media are suggested for high-risk patients.
Conclusions:
- CIN prevention requires careful patient selection and procedural optimization.
- Further research is needed to establish effective pharmacological interventions.
- Choice of contrast media may influence CIN risk in vulnerable populations.
Abstract:
Contrast-induced nephropathy (CIN) is a common complication after diagnostic and therapeutic cardiovascular procedures that is associated with significant mortality and morbidity. CIN is highly prevalent in patients with well-known risk factors, including older age, chronic renal insufficiency, congestive heart failure, and diabetes. Thus far, no strategies have been shown to be effective in preventing CIN beyond thorough patient selection, minimizing the amount of contrast agent, and meticulous hydration of the patient. The role of various drugs in preventing CIN is still controversial and warrants future studies. Despite the remaining uncertainty regarding the degree of nephrotoxicity produced by various contrast agents, nonionic low-osmolar contrast media may be preferred in patients at high risk for CIN.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies VII: Vascular Imaging
Coronary Artery Disease V: Interprofessional Care
